SNAP-8's proposed mechanism involves competition with SNAP-25 for incorporation into the SNARE complex — the molecular machinery that fuses neurotransmitter vesicles with the presynaptic membrane. In cell-free and cell culture assays, SNAP-8 has been shown to reduce the efficiency of SNARE complex formation, which theoretically decreases acetylcholine release at the neuromuscular junction.1

SNAP-8
SNAP-8 is an acetylated octapeptide analog of the N-terminal domain of SNAP-25. It is used in vitro to investigate SNARE complex interactions, synaptic vesicle fusion, and peptide-mediated modulation of exocytosis in neuromuscular and dermal models, supporting structure–activity and vesicle trafficking research under controlled conditions.
Product Overview
SNAP-8 (acetyl octapeptide-3) is a synthetic peptide designed to mimic the N-terminal end of SNAP-25 — a protein that forms part of the SNARE complex responsible for neurotransmitter release at neuromuscular junctions. By competing with native SNAP-25, the peptide is hypothesized to modulate the SNARE complex assembly, reducing neuromuscular activity in the muscle fibers responsible for expression-line formation.
SNAP-8 is an extension of the SNAP-6 concept (acetyl hexapeptide-3, also known as Argireline), with two additional amino acids that may improve receptor binding and potency. It is studied exclusively in the aesthetics/cosmetics research context — its entire research profile centers on the molecular biology of facial expression wrinkle formation.

Mechanism and Experimental Context
SNAP-8 is studied in cell culture models of expression-line biology, including primary keratinocyte and fibroblast cultures from facial skin. Research measures the effect of SNAP-8 treatment on cellular contractility markers and extracellular matrix organization in these models.2
SNAP-8 is widely studied in the cosmeceutical research field as a peptide-based approach to expression line reduction. It represents the pharmaceutical chemistry approach to understanding how small peptides can modulate specific molecular targets in skin biology.
Keep the Research Trail Moving
Source Literature
Blanes-Mira C, et al. "A synthetic hexapeptide (Argireline) with antiwrinkle activity." International Journal of Cosmetic Science, 2002. PubMed: PMID 18498517
Wang Y, et al. "Anti-wrinkle efficacy of acetyl octapeptide-3." Journal of Cosmetic Dermatology, 2013.
Batch Documentation
Current published batch documentation is surfaced on-page whenever the provider exposes a public COA asset.

Frequently Asked Questions
Questions About SNAP-8
SNAP-8 (acetyl octapeptide-3) is a synthetic peptide that mimics SNAP-25, a component of the SNARE complex at neuromuscular junctions. It is studied for its potential to modulate neuromuscular signaling in expression-line research models.
The SNARE complex is molecular machinery that enables neurotransmitter vesicles to fuse with the cell membrane and release their contents. It consists of three proteins: SNAP-25, syntaxin, and VAMP. SNAP-8 is designed to interfere with SNAP-25's role in this complex.
Argireline (acetyl hexapeptide-3) is the 6-amino-acid predecessor. SNAP-8 is the 8-amino-acid version with two additional residues that may improve binding. Both target the same SNARE complex mechanism.
No. SNAP-8 is a research compound sold for laboratory research only.
Its entire research profile is specific to expression-line biology and cosmeceutical science. Unlike other OSYRIS compounds that span multiple research areas, SNAP-8's applications are exclusively in the aesthetics/dermatology context.
Store at 2-8°C, protected from light.
Independently tested via HPLC and LC-MS. COA downloadable on this page.
OSYRIS SNAP-8 is supplied at 500mg. Research protocols vary — consult published literature for relevant concentrations in cell culture and in vitro models.
Every Batch Tested by an Independent Lab
We publish the Certificate of Analysis for every product. See our full testing process.



